On April 8, 2026, Apotex Corp. initiated a Class II recall of Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only.
The recall, identified as D-0510-2026, is classified as Class II by the FDA. The stated reason is a defective container, involving a batch of bottle caps with dislodged or missing cap liners.
The affected product carries NDC 60505-0815-0 and was manufactured by Apotek Inc. in Toronto, Ontario, Canada, for Apotek Corp. in Weston, Florida.
The recall status is listed as ongoing as of the reporting date. No additional details beyond the container defect and classification have been provided in this notice.
This action pertains specifically to the packaging defect described and does not include further characterization of the product's approved use.
Readers can consult the compound overview for general context on desmopressin.